NewAmsterdam Pharma Company
NAMS
#4361
Rank
A$2.87 B
Marketcap
$26.15
Share price
-12.17%
Change (1 day)
-19.54%
Change (1 year)

NewAmsterdam Pharma Company (NAMS) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : A$0.17 Billion

According to NewAmsterdam Pharma Company's latest financial reports the company's total liabilities are A$0.17 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NewAmsterdam Pharma Company - Total liabilities on balance sheet (from 2023 to 2023)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$0.17 B99.87%
2023-12-31A$86.16 M12.87%
2022-12-31A$76.34 M332.02%
2021-12-31A$17.67 M-29.88%
2020-12-31A$25.19 M